We are a clinical-stage biotechnology company focused on restoring function by developing therapeutics that activate a person’s innate regenerative potential.
Frequency is leading a new category in regenerative medicine designed to activate a person’s innate regenerative potential, within the body, to repair tissue and restore function.
Developing small-molecule treatments to reverse the debilitating impact of degenerative diseases
Chairman, In Memoriam
Co-founder, President and CEO
Independent Board Member
Managing Partner, Taiwania Capital Management
Institute Professor, Massachusetts Institute of Technology